Human brain imaging of α7 nAChR with [(18)F]ASEM: a new PET radiotracer for neuropsychiatry and determination of drug occupancy
about
Cholinergic imaging in dementia spectrum disordersPET Imaging of the Human Nicotinic Cholinergic Pathway in AtherosclerosisThe Novel, Nicotinic Alpha7 Receptor Partial Agonist, BMS-933043, Improves Cognition and Sensory Processing in Preclinical Models of Schizophrenia.PET imaging evaluation of [(18)F]DBT-10, a novel radioligand specific to α7 nicotinic acetylcholine receptors, in nonhuman primates.Selected PET Radioligands for Ion Channel Linked Neuroreceptor Imaging: Focus on GABA, NMDA and nACh ReceptorsDevelopment of [(18)F]ASEM, a specific radiotracer for quantification of the α7-nAChR with positron-emission tomographyPET tracers for imaging brain α7 nicotinic receptors: an update.PET imaging of α7 nicotinic acetylcholine receptors: a comparative study of [18F]ASEM and [18F]DBT-10 in nonhuman primates, and further evaluation of [18F]ASEM in humans.[(125)I]Iodo-ASEM, a specific in vivo radioligand for α7-nAChR.Radioligand binding analysis of α 2 adrenoceptors with [11C]yohimbine in brain in vivo: Extended Inhibition Plot correction for plasma protein binding.Molecular imaging of autism spectrum disorder.The distribution of the alpha7 nicotinic acetylcholine receptor in healthy aging: An in vivo positron emission tomography study with [18F]ASEM.Varenicline, the clinically effective smoking cessation agent, restores probabilistic response reversal performance during withdrawal from nicotine.PET Brain imaging of α7-nAChR with [18F]ASEM: Reproducibility, occupancy, receptor density, and changes in schizophrenia.A Promising PET Tracer for Imaging of α₇ Nicotinic Acetylcholine Receptors in the Brain: Design, Synthesis, and in Vivo Evaluation of a Dibenzothiophene-Based Radioligand.Microwave-assisted radiosynthesis of [(18) F]ASEM, a radiolabeled α7-nicotinic acetylcholine receptor antagonist.
P2860
Q26764933-0CA31B23-E831-4F47-B3F6-47C50EEB3525Q26800058-A8801B30-7105-4A21-9957-6C83429CEAACQ36088364-60F50C4C-4BA1-4ECB-8960-DAF44A1C345FQ36522071-16D3F5F7-EF3E-41C6-B97E-50988004639CQ37108643-32ABF486-AC09-4E61-B816-6691D62BD6C0Q38558845-2223B679-CB53-4A85-AF08-A0C71B835C0DQ38584762-7DCDF162-44E4-424C-9A28-6D22E1B719CBQ39000956-FBBF26E9-5773-4C65-B0B0-7CD20F6C428CQ39294038-A61169AE-724E-4F38-928C-2F3C1141DDF0Q47107655-3F99E080-79CC-4B7D-A81D-75E13798B2C7Q47324986-2B3E1971-151F-4182-87D3-436D4D0BBDBEQ47586233-38F7512A-81B3-4428-8489-EEB154D0A775Q50497127-87E3848F-9973-41C7-87D3-F14D338C43F4Q51742249-52FC2E83-03D9-45E7-896A-BE031AFB5442Q52147865-489BEEEE-A622-4AE6-A63A-3F602B89D23AQ53595683-07028938-E384-45FD-B231-AF84C98BB83D
P2860
Human brain imaging of α7 nAChR with [(18)F]ASEM: a new PET radiotracer for neuropsychiatry and determination of drug occupancy
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on October 2014
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Human brain imaging of α7 nAChR with [
@nl
Human brain imaging of α7 nACh ...... etermination of drug occupancy
@en
type
label
Human brain imaging of α7 nAChR with [
@nl
Human brain imaging of α7 nACh ...... etermination of drug occupancy
@en
prefLabel
Human brain imaging of α7 nAChR with [
@nl
Human brain imaging of α7 nACh ...... etermination of drug occupancy
@en
P2093
P2860
P1476
Human brain imaging of α7 nACh ...... etermination of drug occupancy
@en
P2093
Andrew G Horti
Ayon Nandi
Boris Frolov
Daniel P Holt
Dean F Wong
Heather Valentine
Hiroto Kuwabara
James R Brasic
Lorena Gapasin
Martin Pomper
P2860
P2888
P304
P356
10.1007/S11307-014-0779-3
P577
2014-10-01T00:00:00Z